Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial

被引：9

作者：

Bokhari, L. ^{[1
]}

Jones, L. N. ^{[1
]}

Sinclair, R. D. ^{[1
,2
]}

机构：

[1] Sinclair Dermatol, 2-2 Wellington Parade, East Melbourne, Vic 3002, Australia

[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2022年 / 36卷 / 01期

关键词：

PHARMACOKINETICS;

D O I：

10.1111/jdv.17623

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：67 / E66

页数：5

共 50 条

[21] t-Flavanone Improves the Male Pattern of Hair Loss by Enhancing Hair-Anchoring Strength: A Randomized, Double-Blind, Placebo-Controlled Study
Azumi Nagasawa
Etsuji Wakisaka
Hideshi Kidena
Tomoko Nomura
Mitsuyuki Hotta
Hiroyuki Taguchi
Shigeru Moriwaki
[J]. Dermatology and Therapy, 2016, 6 : 59 - 68
[22] Sublingual hyoscyamine for patient comfort during screening sigmoidoscopy: a randomized, double-blind, placebo-controlled clinical trial
Dumot, JA
Verzola, E
Nicol, S
Easley, KA
Vargo, JJ
van Stolk, RU
[J]. GASTROINTESTINAL ENDOSCOPY, 1998, 48 (03) : 283 - 286
[23] t-Flavanone Improves the Male Pattern of Hair Loss by Enhancing Hair-Anchoring Strength: A Randomized, Double-Blind, Placebo-Controlled Study
Nagasawa, Azumi
Wakisaka, Etsuji
Kidena, Hideshi
Nomura, Tomoko
Hotta, Mitsuyuki
Taguchi, Hiroyuki
Moriwaki, Shigeru
[J]. DERMATOLOGY AND THERAPY, 2016, 6 (01) : 59 - 68
[24] Randomized, double-blind, placebo-controlled study of interferon-γ 1b in Friedreich Ataxia
Lynch, David R.
Hauser, Lauren
McCormick, Ashley
Wells, McKenzie
Dong, Yi Na
McCormack, Shana
Schadt, Kim
Perlman, Susan
Subramony, Sub H.
Mathews, Katherine D.
Brocht, Alicia
Ball, Julie
Perdok, Renee
Grahn, Amy
Vescio, Tom
Sherman, Jeffrey W.
Farmer, Jennifer M.
[J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (03): : 546 - 553
[25] Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
Lederman, Seth
Arnold, Lesley M.
Vaughn, Ben
Kelley, Mary
Sullivan, Gregory M.
[J]. ARTHRITIS CARE & RESEARCH, 2023, 75 (11) : 2359 - 2368
[26] Treatment of functional dyspepsia with enteroplant: a double-blind randomized placebo-controlled pilot phase II clinical trial
Sun, X.
Ke, M.
Wang, Z.
Lin, L.
Zhong, H.
Zhang, S.
Tao, L.
Lin, Z.
Wei, Z.
Jin, X.
Xie, X.
Fang, Z.
Li, X.
Zeng, S.
Tang, J.
[J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 : 76 - 76
[27] Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial (CoFAR)
Fleischer, D. M.
Wood, R. A.
Jones, S. M.
Sicherer, S. H.
Liu, A. H.
Stablein, D.
Henning, A.
Mayer, L.
Lindblad, R.
Sampson, H. A.
Burks, A. W.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB66 - AB66
[28] Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial
Pariser, David M.
Bagel, Jerry
Lebwohl, Mark
Yosipovitch, Gil
Chien, Elaine
Spellman, Mary C.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1314 - 1320
[29] Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
Maggie C Walter
Peter Reilich
Simone Thiele
Joachim Schessl
Herbert Schreiber
Karlheinz Reiners
Wolfram Kress
Clemens Müller-Reible
Matthias Vorgerd
Peter Urban
Bertold Schrank
Marcus Deschauer
Beate Schlotter-Weigel
Ralf Kohnen
Hanns Lochmüller
[J]. Orphanet Journal of Rare Diseases, 8
[30] Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
Walter, Maggie C.
Reilich, Peter
Thiele, Simone
Schessl, Joachim
Schreiber, Herbert
Reiners, Karlheinz
Kress, Wolfram
Mueller-Reible, Clemens
Vorgerd, Matthias
Urban, Peter
Schrank, Bertold
Deschauer, Marcus
Schlotter-Weigel, Beate
Kohnen, Ralf
Lochmueller, Hanns
[J]. ORPHANET JOURNAL OF RARE DISEASES, 2013, 8

← 1 2 3 4 5 →